Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  News  >  Companies  >  All News

News : Companies

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance ProfessionalsCalendarSectors

Global Ventricular Arrhythmia API Manufacturers, Marketed and Phase III Drugs Landscape Report 2017-2018 - Research and Markets

share with twitter share with LinkedIn share with facebook
share via e-mail
0
02/17/2017 | 07:52pm CEST

Research and Markets has announced the addition of the "Ventricular Arrhythmia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017" drug pipelines to their offering.

Ventricular Arrhythmia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturers across the globe.

A key objective of the Ventricular Arrhythmia Report is to understand the market and pipeline status of the drugs around the Ventricular Arrhythmia to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline strategies. The Report provides the historical and forecasted sales of the drugs till 2018.

The Ventricular Arrhythmia Report gives insights into patents providing the patent protection data and marketing exclusivity of all the drugs across the Ventricular Arrhythmia.

While the leading brands, companies and chemicals are considered thoroughly, the report also provides details on the Global API Manufacturers across the globe covering Drug Master Filings of US, Europe and API Manufacturers in Asia specifically China and India.

Key Topics Covered:

1. Indication Overview

2. Market Drugs Landscape

3. Global API Manufacturers Assessment

4. Phase III Drugs Landscape

5. Drugs Market Data and Forecasted Sales Figure-2018

6. Marketed Drugs for Ventricular Arrhythmia

7. Phase III Drugs for Ventricular Arrhythmia

8. Discontinued Drugs for Ventricular Arrhythmia

9. Appendix

For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/cs9gkq/ventricular


© Business Wire 2017
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news "Companies"
10:05aBALMER LAWRIE AND : Supply of A4 Size 75 Gsm Jk Brand Copier Papers
AQ
10:05aBALMER LAWRIE AND : E Tender for Supply of Sko in Drums
AQ
10:04aOFFICE EQUIPMENT : Supply and Delivery of Office Equipment
AQ
10:03aOFFICE EQUIPMENT : Supply & Delivery of Office Equipment for Survey Office use, Sipalay City, Negros Occidental.
AQ
10:03aNTPC : Amc for Premium Transsmission Ltd Make Fluid Coupling and Gearbox
AQ
10:03aWAFRAH FOR INDUSTRY AND DEVELOPMENT SJSC : Supply of Food Products for the 2 Nd Half of 2018 (Sugar)
AQ
10:02aNTPC : Procurement of Pipes for Wagon Tippler Hydraulic System of Chp
AQ
10:02aNTPC : Job Contract for Running and Maintenance of Gangotri Guest House for
AQ
10:02aTRANSNEFT' : Ауп / Тсиб / 380/2018/012 «Performance of Works on an Establishment of the Minimum Distances from Objects of the Main Oil Pipelines of Nizhnevartovsk Umn»
AQ
10:02aFORTUM : Conducting Chemical Cleaning of Equipment (Operational Chemical Cleaning of Boilers Bkz-210-140f St. Nos. 9, 13, Ptvm St. Nr.1,4) Tyumen Chp-1 Branch of the Power System "Western Siberia" Pjsc "Fortum" in 2018, 2019 - Lot of Sap Srm F100010331.
AQ
Latest news "Companies"
Advertisement